More on Big Pharma’s decline into crime
It gets worse…
More on Big Pharma’s decline into crime
We finished off the last post with Pfizer paying $116 billion for Warner Lambert to get its hands on Lipitor, one of the world’s biggest seeking blockbuster drugs. This was because the patent was due to expire in 2011 and they had no drug of their own. Read more here:
The long, sorry story of Big Pharma’s decline into crime
The SARS-CoV-2 injections scam has its roots in the 1980s. The Big Pharma companies handed over their supply chain assets, and the people working them, to third party companies.
Pfizer did that because like all the other big pharma companies, their own pipelines had dried up. This was because they sold off all their supply chain assets in the 1980s. Imagine if Ford, Peugeot, BMW etc divested all their design and production capability to let third party companies do it for them. That’s exactly what happened in pharma.
It sparked a massive merger and acquisition extravaganza where the bigger fish ate the smaller fish. That didn’t solve the problem of the patent cliff, of course, but it gave them some breathing space from investor’s banging on CEOs doors.
Then, in 1998, a biologic drug known as a monoclonal antibody (mAb) was approved by US FDA. It was developed …